A speaker wished to ask a practical question about methyldopa: for a patient who was well stabilized on the drug, who had a positive Coombs test but nothing elseand Professor Dacie said that only 1 % or less developed anything more than that -should one in fact change? Were there any long-term ill effects that one should determine to avoid?
The Immunology of Liver Disorders by Geoffrey Walker MD MRCP (St Mary's Hospital, London W2) There has been a very great increase during the last fifteen years in our knowledge of the interrelationships between liver disorders and disturbed immunological processes. It is now recognized that three chronic liver syndromes are associated regularly with autoantibodies in the serum: primary biliary cirrhosis (PBC), active chronic hepatitis (ACH) and cryptogenic cirrhosis. Whether these disorders can be considered as belonging to the group of idiopathic autoimmune diseases is, however, still unresolved although hepatic cirrhosis was one of the first conditions investigated immunologically. Moreover, ideas about hepatitis are changing rapidly since the discovery of the hepatitis-associated (Australia) antigen (HBAg), while the use of polytransfused sera has revealed antigenic materials possibly connected with other viruses which may also be implicated in the pathogenesis of chronic (or acute) liver inflammation.
This review sets out to evaluate immunological phenomena, in particular autoimmune phenomena, as they occur in inflammatory liver disorders, and to discuss their pathogenetic and diagnostic implications. Genetic aspects of the immune processes and their relationships to viruses, drugs and other external factors are also considered. No attempt is made to discuss transplantation of the liver in man or the use of immunological tests for fetal antigens in the serum of patients with primary malignant disease of the liver, although the practical importance of such tests is fully recognized.
Hyperglobulina?mia Hyperglobulinemia in various liver diseases is well recognized but its pathogenesis is uncertain. Synthesis of several different classes of immunoglobulins is increased, but whether this is due to excessive antigenic stimulus, to generalized hyperactivity of the lymphoreticular system, or to both, is not known. One possible stimulus to antibody formation is breakdown of hepatic tissue. Following experimental liver injury, immunoglobulin synthesis is increased and these immunoglobulins consist in part of autoantibodies. The latter, however, are poorly defined and react with a variety of tissues. Alternatively, the stimulus could arise from identified or unidentified infective agents responsible for the liver disease; or, again, the relationship to the liver condition itself may be indirect.
In acute inflammation, as in virus hepatitis, a modest increase in gamma globulin occurs 7-14 days after onset, but this usually returns to normal within a few weeks and persistence of high levels may indicate transition to chronic liver disease and the development of cirrhosis. In this condition, serum protein electrophoresis may show /-y fusion due to increase in the faster globulins (yl) whereas a narrow distinct gamma peak is characteristic of active chronic hepatitis and consists essentially of slower Y2 globulins (Hobbs 1966) . Rarely, a monoclonal picture may be seen.
Serum Immunoglobulin Changes
A generalized rise of one or more serum immunoglobulins is a feature of many acute and chronic liver diseases (Feizi 1968 , Hobbs 1970 . Certain chronic disorders are associated with typical patterns of immunoglobulin elevation. Thus the markedly elevated IgG levels in ACH led to the alternative name of 'hypergammaglobulinemic hepatitis', while IgM elevation is characteristic of primary biliary disease where it may be of help in differentiation from other types of cholestasis. However, as individual cases frequently deviate from the general trend, the diagnostic value of these estimations is strictly limited. In acute viral hepatitis, IgM levels rise early in the illness in both endemic and long-incubation types of the disease (Walker, Doniach, Willette, Cameron & Dane 1970) and immunoglobulin measurements therefore cannot be used to differentiate these two conditions. However, emergence and per-sistence of an elevated IgG level suggests the presence of, or progression to, more sinister chronic inflammation.
The interrelationships of histological pattern, presence of hepatitis-associated antigen (HBAg) and of immunological changes are next considered.
Chronic Hepatitis Chronic hepatitis may arise from persistence of a viral infection or it may be of unknown etiology in which case autoimmune mechanisms have been postulated. Yet other cases may be related to drug ingestion. Chronic hepatic inflammation can follow an attack of jaundice which is indistinguishable from typical acute viral hepatitis or it can develop insidiously without preceding jaundice. Following the discovery of HBAg it has, however, been possible to use it as a marker of infection with the long-incubation hepatitis virus and hence to separate off a proportion at least of chronic hepatitis cases. Chronic persistent hepatitis may follow acute hepatitis and is more likely to occur after longincubation virus infection than after endemic hepatitis. Histological features are expansion of portal triads and increased inflammatory infiltrate, but lobular architecture is preserved and fibrosis is slight (de Groote et al. 1968 , Becker et al. 1970 . The changes may persist for many months but the outcome is usually favourable, progression to cirrhosis being very unusual. If, however, in acute viral hepatitis there is 'bridging' necrosis linking central veins and portal triads (Boyer & Klatskin 1970) the prognosis becomes much worse with regard both to development of chronic liver disease and cirrhosis, and to mortality. It is also established, from studies of asymptomatic subjects with positive HBAg tests, that histological changes as outlined above may be present without clinical jaundice (Singleton etal. 1971) . Active chronic hepatitis may also follow identifiable infection with the long-incubation hepatitis virus, but here the inflammatory cell infiltrate is heavy and consists chiefly of mononuclear cells. The degree of parenchymal necrosis is variable and the term 'piece-meal' necrosis has been used.
There is isolation of individual liver cells and evidence of regeneration. Fibrosis is conspicuous and cirrhosis is a frequent feature. These histological features have given rise to the term 'chronic aggressive hepatitis' (de Groote et al. 1968 ) but this appearance is in itself not pathognomonic of the condition and it should be noted that it more often than not occurs when positive proof of initial viral infection is lacking (Wright 1972) . It may be seen in some patients with Wilson's disease and following drug in-gestion (e.g. oxyphenisatin, methyldopa). The prognosis of active chronic hepatitis (ACH) is poor, few patients surviving for more than 10 years (Mistilis et al. 1968) . ACH is also known by a number of different names including 'plasma cell hepatitis', 'juvenile cirrhosis', and 'lupoid hepatitis'. There may or may not be associated multisystem abnormalities such as colitis, arthritis, skin lesions, renal disorders and thyroiditis.
These histological classifications of chronic hepatitis leave many questions unresolved. Thus the etiology of a fairly high proportion of both 'persistent' and 'aggressive' cases remains obscure (although improved sensitivity of tests for HBAg and further knowledge of its subtypes may clarify the situation to some degree). Factors determining resolution of the hepatitic process or its progression to 'persistent' or 'aggressive' types of chronicity are also largely obscure, but clearly of great importance. Also, it is becoming increasingly apparent that there are several distinct subtypes of the ACH syndrome, and some at least would appear not to be of viral origin. In a recent paper, immunoglobulin studies have confirmed the high incidence of IgG changes in chronic persistent and chronic aggressive hepatitis, although the differences in incidence in HBAg positive and negative cases were not significant (Dudley et al. 1973) . However, in cases which were HBAg-positive, serum IgG levels were significantly higher, suggesting that a different pathogenetic mechanism might be in operation.
General Stimulation ofthe Immune Response in Liver Disease
When evaluating the significance of immunoglobulin changes or other immune phenomena in liver disorders, it is important to take into consideration the response of the reticuloendothelial system to liver injury in general (Popper et al. 1965) . Following parenchymal damage, Kupffer cells proliferate and immunocytes are attracted into sinusoids and portal tracts; this leads in turn to increased immunoglobulin synthesis. These immunoglobulins consist of autoas well as iso-antibodies and various bacterial and viral antibodies. The mechanism could be an increased processing of antigen in the proliferated Kupffer cells, thus triggering antibody synthesis in immunocytes attracted to the liver. Bacterial and viral antibodies are thought to be generally enhanced in hepatitis and cirrhosis and high titres of antibodies to measles and rubella viruses have been described in ACH (Triger, Kurtz, MacCallum & Wright 1972 ). It appears (Triger, Alp & Wright 1972 ) that this applies particularly to enteric organisms, and it has been postulated that in these instances Kupffer cells in the diseased liver fail to sequester antigens, including those ab-sorbed from the gut, and these then become available for antibody formation elsewhere, thus contributing to the observed hyperglobulinemia (Triger & Wright 1973) . New information has suggested that distribution of antigen between liver and spleen may determine the magnitude of the immune response (Thomas et al. 1973 ). In cirrhosis the increased production of antibody to both gut-derived and non-gut-derived antigen may be due to a reduction in capacity of the liver to trap antigen, which results in more antigen reaching the spleen. Portacaval shunts further interfere with the Kupffer cell 'filter' and higher antibody titres are found after such operations. E. coli, Bacteroides, and nutritional antibodies are highest in ACH but also show temporary increases during acute viral infection; the same is true for salmonella antibodies (Protell et al. 1971 , Triger, Alp & Wright 1972 , Bjorneboe et al. 1972 ). Pertinenm to these remarks about by-passing of Kupffer cells are observations implicating the liver in the Chase-Sulzberger effect. It is known that animals fed a hapten are subsequently resistant to sensitization by this hapten. Cantor & Dumont (1967) demonstrated that this specific immunological unresponsiveness could be prevented by portacaval shunt, and this suggests that circulation of antigen to the liver before contact with immunologically competent cells elsewhere decreases the ability of these cells subsequently to recognize or react with antigen.
Autoantibodies in Liver Disease
The autoantibodies produced as part of the 'general activation' already referred to are poorly defined. Early studies (and many later ones) have shown that complement fixation tests (CFT) with crude liver or kidney homogenates can be positive in viral hepatitis, and in alcoholic and other types of cirrhosis (Eyquem & Gurow 1968 ). However, use of these simple CFT with tissue homogenates showed that three chronic liver disorders could be separated off from theii fellows as the reactions occurred at much higher titres (Doniach et al. 1966) . The conditions were primary biliary cirrhosis, active chronic hepatitis and cryptogenic cirrhosis. With the advent of immunofluorescent techniques, it became apparent that high titres of other non-organ-specific, non-species-specific autoantibodies, namely those directed against nuclei, smooth muscle and mitochondria, were also restricted to these disorders with one or two exceptions, discussed below. The concept of non-organ-specific autoimmune 'markers': Most of these autoantibodies found in the serum of patients with liver disease are directed against subcellular organelles or soluble proteins which occur not only in the liver but in many other organs. The antibodies are not now thought to be directly responsible for the progression of liver cell or bile duct destruction and their clinical importance is primarily diagnostic.
They do not occur, however, in alcoholic cirrhosis or in diseases due to metabolic errors such as hemochromatosis and Wilson's disease, where equally severe liver cell damage may nevertheless be present. Hence they cannot be considered simply as epiphenomena secondary to liver-cell injury. Since persistent and high titres are polarized to a small number of recognized clinical liver syndromes, it seems likely that in these cases the antibodies might represent markers of an underlying predisposition to autoimmunity.
They do also occur occasionally in other diseases where disturbed immunological processes are known to exist and in association with a subclinical form of hepatitis , Whaley et al. 1970 ). If patients without overt liver disease but having persistently raised titres of mitochondrial antibodies in their serum are studied closely, minor abnormalities of routine liver function tests (in particular serum alkaline phosphatase levels) may be observed while liver biopsies show changes akin to both active chronic hepatitis and primary biliary cirrhosis. Patchy necrosis of liver cells appears to be universal while there is a variable incidence of aggressive hepatitis, bile duct proliferation and intrahepatic granulomas. These patients also show a high incidence of smooth muscle and antinuclear antibodies while 'biological false positive' tests for syphilis and positive latex agglutination tests (for antiglobulin factors) are also not uncommon. Patients showing these changes are almost invariably suffering primarily from some form of collagenosis, arthritis, thyroiditis or pernicious anemia.
These cases, therefore, show strong similarities to the three chronic liver syndromes discussed earlier, and among the latter it is recognized that overlap occurs and that clinical and histological features may be shared. Thus patients with PBC may present with hepatic decompensation, as in cryptogenic cirrhosis, while cholestatic forms of the latter disease occur (Datta et al. 1963) . Cryptogenic cirrhosis patients who have autoantibodies in their serum have higher serum alkaline phosphatase values than antibodynegative cases and are usually middle-aged females, many of whom also have evidence of thyroiditis and Sjogren's syndrome (Ross et al. 1974 ). Liver biopsies in these patients show features reminiscent of biliary disease. Again, bile-duct lesions are described in acute and chronic viral hepatitis, where they occur chiefly in women, although these lesions may be slightly different from those encountered in classical PBC (Christoffersen et al. 1972 ). Patients showing histological features of both ACH and PBC are nevertheless known to occur (Popper & Schaffner 1970) .
These interrelationships between the three chronic liver syndromes and the patients with subclinical hepatitis, and the association with persistent autoimmunity, have led to a unified concept of autoallergic hepatitis probably based on one or more genetic factors (Doniach & Walker 1969 ). Genetic factors in autoimmune livcr disease: In primary biliary cirrhosis, family studies have shown a significant increase of autoantibodies in unaffected relatives (Feizi et al. 1972 ) while this condition may occur in more than one member of a family (Walker et al. 1972 , Galbraith et al. 1974 . Active chronic hepatitis is also described in families (Joske & Laurence 1970 , Whittingham et al. 1970 , Galbraith et al. 1973 . Interplay of three factors has been postulated in these patients, namely a genetic predisposition to liver disease, a tendency to autoimmunity and an external factor, in all probability the hepatitis virus. Predilection of these conditions for persons with certain tissue types and blood groups is also now appearing and this again highlights the importance of genetic factors (Mackay & Morris 1972) .
Other evidence supporting a selective autoimmune nature for these patients' diseases consists of the strong female sex incidence, and the presence of multisystem involvement. With regard to the latter, the incidence of renal tubular acidosis and Sjogren's syndrome is striking (Golding et al. 1973 ).
Pathogenesis of 'autoimmune' liver disease:
There is no evidence to support any direct cause-andeffect relationship between the non-organspecific autoantibodies which appear in the serum and the chronic destructive processes going on in the liver. Could cell-mediated immune mechanisms provide the 'missing link'? Studies of cellular immunity to liver homogenates have been carried out in man, utilizing the lymphocyte transformation test in active chronic hepatitis and various types of cirrhosis in response to challenge with liver biopsy tissue; human fetal liver homogenate has also been used in the migration inhibition test (Bacon et al. 1972 , Smith et al. 1972 . Positive results were obtained in 30 60O% of cases of ACH and PBC and as a temporary phenomenon in viral hepatitis but not in normal controls or in extrahepatic biliary obstruction. The organ-specificity of these reactions is not yet clear, as some patients react also with salivary gland or kidney extracts, and this is particularly common in the presence of Sj6gren's syndrome or renal tubular acidosis. Correlation between the presence of serum autoantibodies and positive tests for cell-mediAted immunity is imperfect. In patients with primary biliary cirrhosis and a positive serum mitochondrial antibody test, Brostoff (1970) demonstrated migration inhibition of leukocytes by rat liver mitochondria (as antigen) in about half the cases. Surprisingly, inhibition was also noted in two-thirds of patients with Hashimoto's thyroiditis (who were acting as controls). The mitochondrial leukocyte migration inhibition test (LMT) appears to occur in a wide spectrum of autoimmune diseases (including those affecting the thyroid, stomach and adrenal) and can also develop after tissue injury, as seen following myocardial infarction or surgical operation. Its exact relationship to cellular destruction, inflammatory response and cell-mediated immunity remains uncertain (Wartenberg et al. 1973 ). Further work with LMT employing standardized subcellular fraction checked for contamination with microsomes and organ-specific cell surface antigens may help clarify the situation. A liverspecific lipoprotein isolated from human liver (Meyer zum Buschenfelde & Miescher 1972) has also been used as antigen in LMT: again, positive reactions were confined to active chronic hepatitis and primary biliary cirrhosis, being present in two-thirds and a half of these cases respectively (Miller et al. 1972) . Reasons for negative results in the remaining cases are obscure and the exact role of autoimmunization to this lipoprotein in the pathogenesis of the liver lesions themselves is unclear.
Practical Applications ofAutoantibody Tests
Antinulclear antibodies (ANA): These are best detected by indirect immunofluorescence on fresh rat liver sections. The highest incidence (approximately 75 %) is seen in 'lupoid' hepatitis, where LE cell tests are positive, but high titres in excess of 2000 may also be found in ACH when the LE cell test is negative. In such instances it is possible that an inhibitor in the serum is responsible for the negative LE cell test. ACH patients may, however, have ANA titres of only 10 or 20, yet the LE cell test may be positive; rarely, LE cells may be found without ANA fluorescence. The nuclear staining pattern is usually diffuse in ACH and the antibodies predominantly of IgG class. In PBC and cryptogenic cirrhosis approximately 500% of ANA-positive cases show speckled patterns or, more rarely, nucleolar antibodies. In all these conditions the serum may contain a mixture of ANA reacting with several nuclear constituents which show up by a change of pattern with increasing dilution or when using conjugates specific for the main Ig classes. The highly sensitive radioimmunoassay for DNA and .RtA antibodies may be of help in predicting acute exacerbations in lupoid hepatitis, as in systemic lupus erythematosus (Carr et al. 1969 ) and may find wider application when the necessary radioactive substrates become more available.
ANA was the first 'marker' which was believed to distinguish 'autoimmune' cases of chronic hepatitis from cases of prolonged 'simple' viral hepatitis. Among patients with an 'aggressive' liver histology, it tended to be more positive in women whereas HBAg may be more frequent in males (Vischer 1970) . However, the difficulty in using ANA as a marker of an innate autoimmune predisposition is that these ant ibodies can be stimulated by drugs, when they appear in a high proportion of unselected people. ANA may be present in as many as 60% of patients after procainamide treatment while SLE-like syndromes also occur after hydrallazine, methyldopa, isoniazid and penicillin. Reports have now appeared, however, of ACH and 'lupoid' hepatitis in patients taking laxatives containing oxyphenisatin; the LE cells, ANA and hepatic inflammation apparently regress when the drug is discontinued (Reynolds et al. 1971 , Pearson et al. 1971 . Another diagnostic difficulty is that a positive ANA of low titre is not uncommon in healthy elderly subjects while the antibodies also occur in collagen disorders and autoimmune diseases not affecting the liver and this should be borne in mind when the test is used in diagnosis of liver disease.
ANA tests are positive in about 25% of PBC and cryptogenic cirrhosis patients (Doniach et al. 1966 ). In the latter it may occur in patients without any other evidence of autoimmunity, while in PBC it is found particularly in the small proportion of patients who fail to react with mitochondria.
Viruses are also known to induce ANA and lupus-like disease, particularly in certain inbred strains of animals (e.g. LE-nephritis in New Zealand Black/White hybrid mice). In humans, ANA is found only rarely in uncomplicated viral hepatitis. There are, however, well-authenticated cases of HBAg-positive viral hepatitis progressing to a chronic stage with ANA and LE cells and perhaps this occurs in genetically predisposed individuals.
Smooth muscle antibody (SMA): This is most satisfactorily detected on fresh unfixed rat stomach sections or on human cervix. The antigen is probably an actomyosin-like protein present near the cell membrane in many tissues. It is unstable, gradually losing potency in tissue kept frozen for several weeks. Sera must be tested at dilutions of at least 10, since even then some normal subjects show positive reactions.
In the context of differential diagnosis in liver disease, this 'marker' was once believed to be specific for active chronic hepatitis (Johnson et al. 1965) and titres greater than 80 are rarely found in viral hepatitis, although in one report the test was positive at a dilution of 320 in a patient with positive HBAg tests who subsequently recovered, whereupon the antibody disappeared (Grob & Jemelka 1971) . Over 60% of patients with viral hepatitis have a temporary trace of these antibodies (Walker, Doniach, Willette, Cameron & Dane 1970 , Farrow et al. 1970 , whereas in patients showing progressive liver involvement they may persist for many years. In acute viral hepatitis the antibodies appear early, titres of 10-80 being most frequent in the first week of illness. Thereafter the titres decline and most patients give negative results at 13 weeks. SMA shows no preference for the female sex or for older age groups. This is the opposite to what is found in the more familial types of autoimmunity. In endemic viral hepatitis, there is a correlation between serum bilirubin level and SMA titre, suggesting that liver cell damage is the main stimulus to antibody formation in these particular circumstances.
In a recent study (Dudley et al. 1973) it was found that the highest titres of SMA occurred in HBAg-negative cases of aggressive hepatitis where the incidence differed from that in HBAgpositive cases, suggesting a different pathogenetic mechanism in the two circumstances. These patients also not infrequently had positive tests for ANA and mitochondrial antibodies which were not found in HBAg-positive cases. Approximately 45% of PBC patients have some smooth muscle fluorescence but titres are low. The incidence of cryptogenic cirrhosis depends greatly on the selection of material; in cases with other evidence of autoimmunity it is around 40%.
Smooth muscle antibodies are not confined to liver diseases: a high incidence has been described in infectious mononucleosis without liver involvement and in the serum of patients with various tumours (Holborow 1972) .
Mitochondrial (M) Antibodies
These antibodies have proved the most useful from a diagnostic point of view. They are also considered to be the most reliable 'markers' of autoimmune liver disease.
Incidence in liver diseases: 85-95 % of PBC patients give positive immunofluorescence, an overall figure of 88 % being observed in five of the earliest published series (Doniach, Walker, Roitt & Berg 1970) . Recently, in a large series from Yale, Klatskin & Kantor (1972) report an incidence of 84%. In about a half of PBC cases, titres are high, with fluorescence of 200-60 and correspondingly high CFT. In the remainder, titres are moderate or low. There is no correlation with the duration or stage of the disease and titres tend to iemain unchanged on follow up. Patients with established primary biliary cirrhosis and a negative antibody test do not differ clinically or histologically from their antibodypositive counterparts (Hadziyannis et al. 1970) . The antibodies are found in all three main immunoglobulin classes and bear no relation to the level of serum 1gM, which is frequently elevated. They do not appear in the bile. Treatment with corticosteroids and azathioprine does not inhibit their formation (Fischer & Schmid 1967) nor does orthotopic liver transplantation, although there is a temporary drop in titres due to blood replacement during operation (Smith et al. 1971 ). Since the diseased liver is removed in these patients, continued synthesis of mitochondrial antibodies suggests that there is a primary abnormality of the immune system resulting in autoimmunization to mitochondria and that this is independent of changes in hepatic antigens. In ACH and cryptogenic cirrhosis the incidence of mitochondrial antibodies varies greatly according to diagnostic criteria and in different countries: it is probably about 25 % in both. In other types of cirrhosis the antibodies are rarely found. Negative results have been obtained in several series of infective hepatitis cases which included HBAg positive and negative patients as well as in jaundice due to infective mononucleosis (Walker, Doniach, Willette, Cameron & Dane 1970) . A few cases of chlorpromazine jaundice have had transient mitochondrial reactions and positive results have been found in halothane hypersensitivity (Walker et al. 1967 , Rodriguez et al. 1969 ). Titres are low and the antibodies disappear upon clinical recovery. The significance of these findings is uncertain.
The primary practical value of tests for M antibodies is in the differentiation of extrahepatic ('surgical') obstruction of main bile ducts from various types of intra-hepatic cholestasis. In these circumstances repeatable M antibody tests at appreciable titres make the presence of 'surgical' jaundice extremely unlikely, provided the patient is not suffering from some other disease (e.g. collagenesis) where M antibodies also occur (see below). It should also be remembered that patients with PBC have an increased incidence of gall-stones and the two conditions may therefore present together (Block et al. 1969 ). The accumu-lated experience of 6 published series spread over a nine-year period shows that in main-duct biliary obstruction, even when a secondary biliary cirrhosis has developed, the mitochondrial antibody test remains negative (Doniach, Walker, Roitt & Berg 1970 , Klatskin & Kantor 1972 . By contrast, Lam et al. (1972) have recently reported positive M tests in a variety of forms of prolonged cholestasis as well as in 'surgical' obstruction of the bile ducts. The reasons for this discrepancy are not yet fully apparent but it is possible that heterophile antibodies reacting with animal tissue (Ireton et al. 1971 , Muller et al. 1971 , Strickland & Hooper 1972 provide the explanation for these positive results and the arguments in favour of this are presented in detail elsewhere (Doniach & Walker 1974) . In a recent study of patients selected on the basis of a positive mitochondrial antibody test, Kaplowitz et al. (1973) found an appreciable number with cholestasis and extrahepatic obstruction of the biliary tree. When the latter was relieved, however, the antibody tests did not revert to negative and it was felt that they were acting as a marker for some underlying intrahepatic inflammatory process related to PBC. Incidence in 'normal' populations and nonhepatic disease: The incidence in healthy people is 0.4-0.7% (Blajchman 1971 , Bundey et al. 1972 ). However, in nonhepatic autoimmune disorders, e.g. Hashimoto's thyroiditis, pernicious anemia, Addison's disease and myasthenia gravis, the incidence is 1.5-3%. In collagen disorders the frequency is still higher (except in uncomplicated rheumatoid arthritis). In systemic lupus erythematosus it is about 5 % and in Sjogren's syndrome or systemic sclerosis approximately 8 %. These patients may have subclinical liver disease (see above). The highest incidence of mitochondrial antibodies outside chronic liver disease is found in chronic biological false positive reactors who have no evidence of any liver dysfunction (Doniach, Delhanty, Lindqvist & Catterall 1970) . In about half, the mitochondrial fluorescence is of low titre and usually confined to the IgM class. Some of these patients have rheumatoid arthritis, Sjogren's syndrome or SLE, but of interest is a group of female patients presenting with a neurological syndrome diagnosed initially as multiple sclerosis but who have serological features of a collagen disorder and for which the name 'lupoid sclerosis' has been proposed (Fulford etal. 1972 ).
Detection and nature of mitochondrial antibodies:
The standard immunofluorescence technique is employed using unfixed cryostat sections from a composite block of human thyroid and stomach and rat kidney and liver. Screening tests are done with the patient's serum diluted to 1 in 10. As a rule end-points are similar for IgG and IgM classes and with anti-fllc conjugates, but IgA fluorescence is usually weaker. Renal tubules are uniformly stained, the distal tubules and loops of Henle giving the brightest staining. Thyroid cells show a dull granular pattern except for oxyphil cells which fluoresce intesnsely, being packed with hypertrophied mitochondria. Gastric parietal cells are uniformly stained and have a compact appearance while chief cells are darker and granular. When mitochondrial fluorescence is positive it is difficult to see organ-specific thyroid cytoplasmic and gastric parietal cell antibodies which may be present in the same serum.
Mitochondrial antibodies are complementfixing but vary greatly in the amount of complement they are able to fix. This probably explains discrepancies which may occur between titres obtained by immunofluorescence using anti-,Blc conjugates and conventional complemontfixing tests with purified rat liver mitochondria. Some sera with poor CF capacity may fluoresce up to dilutions of 600 and yet be negative by CFT. The reverse may also be seen where sera react by CFT in high titre while fluorescence is 10 or even less. Proof of the localization of the antigen in a lipoprotein of the mitochondrial inner membranes has obtained further support from studies using affinity chromatography, its molecular weight being in the region of 180 000 (Ben-Yoseph et al. 1974 ). It has also been visualized by electron microscopy using peroxidase-coupled PBC immunoglobulins (Bianchi et al. 1973) . Several immunofluorescence patterns may be confused with that produced by M antibodies. The cardiolipin fluorescent antibody is detected mainly in secondary syphilis and very occasionally in patients who are chronic biological false positive reactors (Wright & Doniach 1971) . This antibody gives the same fluorescence pattern as M antibodies but can be easily absorbed out with cardiolipin which does not affect M reactions. A ribosomal immunofluorescence has been identified in a small proportion of patients with SLE. This stains kidney tubules, liver and other organs. A distinction from M antibody can be made since this antibody stains gastric oxyntic cells rather thanparietal cells and its pattern on certain other organs, e.g. pancreas, is different (Homberg et al. 1974) .
From the point of view of diagnosis in liver disorders, however, the microsomal liver/kidney autoantibody (LKM) is of the greatest importance. This antibody was at first thought to be a variant of M (Doniach & Walker 1972) . It produces staining mainly of proximal renal tubule3 and hepatocytes. It is best differentiated from M by use of kidney sections from the rat, since the smaller organ allows inclusion of the medulla which stains brightly with M antibody and remains negative with LKM (Rizzetto et al. 1973) . Localization of the antigen to microsomal membranes has been confirmed by immunoelectron microscopy (Rizzetto et al. 1974) .
The LKM autoantibody is uncommon and is found mainly in cases of ACH. Here it selects a subclass of patients who are usually young and who show little ANA or SMA, unlike classical 'lupoid' hepatitis. There is no evidence of female predominance; a few patients have positive tests for HBAg. This antibody has also been found in a number of cases of drug and viral hepatitis and other liver conditions (Smith etal. 1974 (Chairman) asked what did Dr Walker think happened in that rather striking New South Wales observation on the positive mitochondrial antibodies found in cases of extrahepatic obstruction where the jaundice had been present for more than six weeks. They made a point of the time, almost as though the duration of obstruction had evoked the mitochondrial reaction.
Dr Walker replied that in the five series summarized earlier and containing 253 patients with cholestasis due to main duct obstruction, only two had shown low titres of mitochondrial antibodies. Klatskin & Kantor (1972) in a recent large series from Yale reported similar findings. A partial explanation of the Australian data might lie with the organs used for the immunofluorescent tests. Rat stomach parietal cells might show fluorescence in normal subjects due to the presence of heterophile antibodies and the same applied to rat kidney where the so-called brushborder antibodies could be mistaken for mitochondrial reactions.
Professor Lessof asked if Dr Walker could say more about the evidence which had led him to think that the new microsomal antibodies were not mitochondrial.
Dr Walker replied that it had been recognized for some years that some patients with active chronic hepatitis believed to have mitochondrial antibodies showed an atypical staining pattern on kidney sections. It was now apparent that a proportion of these at least had a distinctive autoantibody which reacted with liver and kidney and had now been shown by immuno-electronmicroscopy to react with the rough endoplasmic reticulum which was part of the microsomal fraction. Dr W J Irvine said that it would help the idea of immunology having importance in the pathogenesis of liver disease if there were evidence that the liver contained a specific antigen, not always a nonspecific antigen. Would Dr Walker comment on the present status ? Dr Walker replied that over the years there had been a number of reports suggesting the presence of liverspecific antigens which then did not satisfy criteria for specificity. However, work was at present in progress on the liver-specific cell membrane lipoprotein, isolated by Meyer zum Buschenfelde. Immunization of animals with this material could produce a chronic hepatitis. The group at King's College Hospital were looking at this lipoprotein, the so-called LP2, in relaticn to leukocyte migration inhibition tests. With this antigen a good proportion of patients with active chrcnic hepatitis or primary biliary cirrhosis showed migration inhibition. The exact role in pathogenesis was, however, still undefined.
